Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56+ NK cells in vitro.

Source:http://linkedlifedata.com/resource/pubmed/id/10903777

J. Immunol. 2000 Aug 1 165 3 1659-64

Download in:

View as

General Info

PMID
10903777